Rettinger, E., & Dürken, M. (2017). Pre-emptive immunotherapy for clearance of molecular disease in childhood acute lymphoblastic leukemia after transplantation. Biology of blood and marrow transplantation, 23(1), . https://doi.org/10.1016/j.bbmt.2016.10.006
Chicago-Zitierstil (17. Ausg.)Rettinger, Eva, und Matthias Dürken. "Pre-emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia After Transplantation." Biology of Blood and Marrow Transplantation 23, no. 1 (2017). https://doi.org/10.1016/j.bbmt.2016.10.006.
MLA-Zitierstil (9. Ausg.)Rettinger, Eva, und Matthias Dürken. "Pre-emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia After Transplantation." Biology of Blood and Marrow Transplantation, vol. 23, no. 1, 2017, https://doi.org/10.1016/j.bbmt.2016.10.006.